DFV890

A Phase 1b, Open Label, Multi-center, Dose Optimization and Dose Expansion Study to Assess the Safety and Efficacy of DFV890 in Adult Patients With Myeloid Diseases

Near Add Your Location

Sorting 16 by

MDS Center of Excellence

  • Accepting patients
  • Show Principal Investigator

MDS Center of Excellence

All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trials

MDS Center of Excellence

Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of Medicine
Chicago, IL
  • Accepting patients

MDS Center of Excellence

  • Accepting patients

MDS Center of Excellence

  • Accepting patients

MDS Center of Excellence

MDS Center of Excellence

  • Accepting patients

MDS Center of Excellence

MDS Center of Excellence

  • Accepting patients

MDS Center of Excellence

Vanderbilt-Ingram Cancer Center
Henry-Joyce Cancer Clinic
Nashville, TN
  • Accepting patients
511 hidden based on your filters. Show All

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print this trial to share with your doctor.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.